Page last updated: 2024-10-25
ciglitazone and Otitis Media
ciglitazone has been researched along with Otitis Media in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Otitis Media: Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Jun, HJ | 1 |
Lim, HW | 1 |
Choi, J | 1 |
Jung, HH | 1 |
Chae, SW | 1 |
Other Studies
1 other study available for ciglitazone and Otitis Media
Article | Year |
---|---|
Ciglitazone inhibits cigarette smoke solution-induced inflammatory responses in human middle ear epithelial cells.
Topics: Blotting, Western; Cells, Cultured; Cytokines; Ear, Middle; Epithelial Cells; Humans; Inflammation; | 2012 |